CVALF (Covalon Technologies) Accounts Payable & Accrued Expense: $2.31 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CVALF Covalon Technologies Ltd CVALF
80 GF Score
Price $2.15
GF Value $1.61
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Covalon Technologies Accounts Payable & Accrued Expense?

Covalon Technologies CVALF -0.42% 80 Accounts Payable & Accrued Expense is $2.31 Mil as of Jun. 2026. GuruFocus rates CVALF with a GF Score™ of 80/100 and a GF Value™ of $1.61 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Covalon Technologies's quarterly accounts payable & accrued expense declined from Dec. 2025 ($2.76 Mil) to Mar. 2026 ($2.39 Mil) and declined from Mar. 2026 ($2.39 Mil) to Jun. 2026 ($2.31 Mil).

Covalon Technologies's annual accounts payable & accrued expense declined from Sep. 2023 ($3.30 Mil) to Sep. 2024 ($2.45 Mil) and declined from Sep. 2024 ($2.45 Mil) to Sep. 2025 ($2.27 Mil).

Covalon Technologies Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Covalon Technologies's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Covalon Technologies Accounts Payable & Accrued Expense Chart

Covalon Technologies Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.19 2.79 3.30 2.45 2.27

Covalon Technologies Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.07 2.27 2.76 2.39 2.31
CVALF
80GF Score
Covalon Technologies Ltd CVALF
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Covalon Technologies Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of $2.31 Mil mean?
Covalon Technologies (CVALF) has a Accounts Payable & Accrued Expense of $2.31 Mil as of Jun. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Covalon Technologies and its competitors.
Is Covalon Technologies' Accounts Payable & Accrued Expense too high?
Covalon Technologies' current Accounts Payable & Accrued Expense is $2.31 Mil. Overall, Covalon Technologies has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Covalon Technologies' Accounts Payable & Accrued Expense compare to ISRG and BDX?
Covalon Technologies' Accounts Payable & Accrued Expense of $2.31 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Medical Devices & Instruments company?
A good Accounts Payable & Accrued Expense depends on the Medical Devices & Instruments industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Covalon Technologies and its competitors. Covalon Technologies's current Accounts Payable & Accrued Expense is $2.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Covalon Technologies stock overvalued right now?
Based on GuruFocus' analysis, Covalon Technologies (CVALF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.61, compared to a current price of $2.15 — trading 33.7% above its estimated fair value. The current Accounts Payable & Accrued Expense is $2.31 Mil. Covalon Technologies' overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Covalon Technologies (CVALF), the current Accounts Payable & Accrued Expense is $2.31 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Covalon Technologies (CVALF) Overvalued in 2026?

Based on GuruFocus' analysis, Covalon Technologies stock appears to be overvalued. The current stock price of $2.15 is trading 33.7% above its estimated GF Value™ of $1.61. GuruFocus considers Covalon Technologies to be Significantly Overvalued.

Key valuation signals for CVALF:

  • Accounts Payable & Accrued Expense: $2.31 Mil
  • GF Value™: $1.61 vs. price of $2.15 (33.7% above fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Covalon Technologies Business Description

Other Exchanges COV:Canada
Address 1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
80GF Score

Get the complete analysis for CVALF

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.15
Price
$1.61
GF Value